# GDES_V7_1_LONGITUDINAL_CLINICAL_MANAGEMENT_AND_PILOT_VALIDATION.md

# GDES Version 7.1
## Longitudinal Clinical Management & Pilot Validation

**Project:** Glomerular Disease Expert System (GDES)

**Audience:** OpenCode Development Team

**Priority:** HIGHEST

**Status:** Post-Release Candidate Development

---

# Background

GDES has successfully completed its software engineering phase.

Current platform status:

- Registry Platform ✓
- Clinical Workflow ✓
- Clinical Decision Support ✓
- Knowledge Platform ✓
- Clinical Governance ✓
- Recommendation Traceability ✓
- AI Explainability ✓
- Research Framework ✓
- Desktop Deployment ✓
- 195 Automated Tests Passing ✓

The project is now technically mature.

The next phase is **not software expansion**.

The next phase is **clinical maturity**.

From this point forward, every development decision must directly improve patient care, clinician workflow, automated follow-up, or research capability.

---

# Guiding Principle

Every proposed feature must answer one question:

> **Does this make the registry more useful for clinicians, improve automated patient management, strengthen follow-up, or enhance research capability?**

If the answer is **YES**, it belongs in Version 7.1.

If the answer is **NO**, defer it to a future release.

---

# Overall Objective

Transform GDES from a technically complete software platform into a clinically validated nephrology management system.

Future development should focus on **clinical value**, not software complexity.

---

# Workstream 1 — Automated Longitudinal Care Pathway Engine

## Priority: CRITICAL

Current status:

GDES successfully provides:

- Differential diagnosis
- Suggested investigations
- Management recommendations
- Monitoring plans
- Follow-up schedules

The missing component is continuous longitudinal patient management.

The system should actively guide patient care over months and years.

---

## Required Capabilities

Each disease should have a complete care pathway.

Example:

Patient Registration

↓

Clinical Assessment

↓

Laboratory Evaluation

↓

Kidney Biopsy

↓

Diagnosis Confirmation

↓

Disease Risk Stratification

↓

Guideline-Based Treatment

↓

Scheduled Follow-up

↓

Automatic Monitoring

↓

Response Assessment

↓

Treatment Escalation

↓

Maintenance Therapy

↓

Relapse Detection

↓

Long-Term Outcome

The pathway should automatically update after every encounter.

---

## Disease-Specific Workflow

Each disease should contain:

- Initial management
- Follow-up frequency
- Required investigations
- Drug monitoring
- Response evaluation
- Remission criteria
- Partial response criteria
- Treatment failure criteria
- Relapse criteria
- Escalation pathway
- Referral recommendations
- Transplant considerations
- Research eligibility

---

## Automated Triggers

The system should automatically detect:

- missed appointments
- overdue laboratory investigations
- overdue biopsy review
- declining eGFR
- increasing proteinuria
- relapse
- treatment toxicity
- lack of treatment response
- disease progression

Every trigger should generate appropriate recommendations.

---

# Workstream 2 — Research Automation Engine

## Priority: VERY HIGH

Research should become automatic.

Whenever patient data changes, GDES should evaluate:

- registry eligibility
- observational study eligibility
- clinical trial eligibility
- missing research variables
- consent requirements
- follow-up requirements

---

## Automatic Study Matching

Example:

Patient

↓

IgA Nephropathy

↓

Proteinuria >1 g/day

↓

eGFR 45

↓

Oxford Score M1E0S1T0C0

↓

Eligible Studies

- Registry
- IgAN Cohort
- CKD Progression Study

↓

Notify Investigator

No manual screening should be required.

---

## Automated Research Outputs

Generate:

- research cohort lists
- missing variable reports
- study recruitment reports
- follow-up compliance reports
- export-ready datasets

---

# Workstream 3 — Pilot Analytics Dashboard

## Priority: HIGH

Create a dashboard specifically for pilot monitoring.

---

## Daily Dashboard

Display:

- New patients
- Follow-up patients
- New GN diagnoses
- Relapses
- Admissions
- Pending biopsies
- Pending pathology reports

---

## Weekly Dashboard

Display:

- Missed visits
- Overdue investigations
- SMS reminders sent
- AI overrides
- New research enrollments

---

## Monthly Dashboard

Display:

- Complete remission
- Partial remission
- CKD progression
- ESRD
- Mortality
- Research recruitment
- Registry completeness
- Missing data
- Guideline adherence

These reports should require no manual data processing.

---

# Workstream 4 — Knowledge Maturation

## Priority: HIGH

Do **NOT** add new diseases.

Instead, improve existing diseases.

Every disease should include:

- detailed treatment algorithms
- monitoring schedules
- relapse pathways
- drug toxicity management
- infection prevention
- vaccination guidance
- pregnancy considerations
- pediatric considerations (where applicable)
- transplant considerations
- prognosis
- patient counselling
- referral criteria
- research recommendations

Depth is now more valuable than breadth.

---

# Workstream 5 — Clinical Validation

## Priority: HIGHEST

Software testing is complete.

Clinical validation now begins.

---

## Retrospective Validation

Review at least 100 historical patients.

Compare:

- physician diagnosis
- AI diagnosis

Compare:

- physician treatment
- AI treatment

Compare:

- physician follow-up
- AI follow-up

Document:

- agreement
- disagreement
- reasons

---

## Prospective Pilot

During routine clinic:

Measure:

- consultation time
- usability
- clinician acceptance
- guideline adherence
- patient compliance
- follow-up completion
- AI override frequency

These findings will guide future refinement.

---

# Workstream 6 — Continuous Knowledge Improvement

Every clinician override should become structured learning.

Capture:

- recommendation
- clinician decision
- override reason
- final diagnosis
- patient outcome

Use these cases to improve the knowledge base.

Knowledge engineering should become a continuous process.

---

# Workstream 7 — User Experience Refinement

Observe clinicians during real use.

Evaluate:

- navigation
- number of clicks
- duplicate data entry
- screen organization
- clarity of recommendations
- traceability usability

Simplify wherever possible.

Clinical workflow should always take priority over software elegance.

---

# Workstream 8 — Research Publication Readiness

Prepare the pilot to generate publishable evidence.

Potential studies:

- Diagnostic agreement study
- AI-assisted management study
- Guideline adherence study
- Follow-up improvement study
- Registry completeness study
- Clinical workflow efficiency study
- Research automation study

The pilot itself should produce evidence supporting GDES.

---

# Deliverables

Produce:

- GDES_LONGITUDINAL_CARE_PATHWAY.md
- GDES_RESEARCH_AUTOMATION_ENGINE.md
- GDES_PILOT_ANALYTICS_DASHBOARD.md
- GDES_CLINICAL_VALIDATION_PROTOCOL.md
- GDES_RETROSPECTIVE_VALIDATION_PLAN.md
- GDES_PROSPECTIVE_PILOT_PROTOCOL.md
- GDES_CONTINUOUS_KNOWLEDGE_IMPROVEMENT.md
- GDES_USER_EXPERIENCE_REVIEW.md
- GDES_RESEARCH_PUBLICATION_PLAN.md

---

# Definition of Success

Version 7.1 will be considered complete when:

✓ Longitudinal care pathways actively manage patients throughout their disease course.

✓ Research enrollment and study matching occur automatically.

✓ Pilot analytics are available in real time.

✓ Existing diseases have deeper, clinically comprehensive knowledge.

✓ Clinical validation has started with retrospective and prospective cases.

✓ Clinician feedback is systematically captured.

✓ Knowledge refinement is driven by real-world clinical experience.

✓ The pilot demonstrates measurable improvements in diagnosis, management, follow-up, and research capability.

---

# Future Direction

From Version 7.1 onward, GDES should evolve through **clinical evidence**, not feature accumulation.

Every enhancement should be supported by:

- clinician feedback
- pilot experience
- patient outcomes
- guideline updates
- published evidence

This approach ensures that GDES remains focused on its mission:

> **To provide an integrated Glomerular Disease Registry, Clinical Decision Support, Automated Longitudinal Management, Follow-up, and Research Platform that improves patient care while supporting high-quality nephrology research.**